Bimekizumab for treating ankylosing spondylitis TS ID 10334Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Sarilumab for treating polyarticular or oligoarticular juvenile idiopathic arthritis in people 2 to 17 years TS ID 10237Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Deucravacitinib for treating active psoriatic arthritis TS ID 11981Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Digital platforms for community based self-management of mild to moderate osteoarthritis and joint pain: Early value assessmentStatus:Awaiting developmentProgramme:Health technology evaluationExpected publication date: TBC